Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Pharmaceutical ManufacturingPsychedelic-Focused Manufacturers
Research, Drug Development & Manufacturing

Optimi HealthCSE: OPTI

1 Trial

Canadian GMP-certified manufacturer of pharmaceutical-grade psilocybin and MDMA, licensed by Health Canada. Optimi's facility in Princeton, British Columbia is one of the largest legal psilocybin production operations in North America. Supplies clinical trial material to researchers in Australia, Israel, and Canada.

Manufacturing Snapshot

Psychedelic-Focused Manufacturer

Scope & Capabilities

API ProductionDrug Product ManufacturingControlled Substance Logistics

Supply Use Cases

Authorized Medical AccessClinical TrialsResearch Use

GxP / Compliance

GMP

Facilities & Access

Purpose-built facility in British Columbia with direct-to-clinic distribution model.

Manufacturing Details

Supported Substances

MDMA and psilocybin products for regulated clinical and research channels.

Regulatory Authorizations

1 authorization

Canada - Health Canada

Active

Drug Establishment License

View source

Manufacturing Sources

Optimi Health

https://optimihealth.ca/

Quick Facts

Type
Public Biotech
Ticker
CSE: OPTI
Website
Visit

Sponsored Trials

1
WithdrawnI

Mood and Cognitive Effects of Psilocybin in Healthy Participants (MELO)

Start Date
Compounds
Placebo, Psilocybin